Drug intelligence / Profile preview

allosamizoline

Development stage
Unknown
Modality
Small Molecules
01

Overview

Allosamizoline is a synthetic small molecule and a cyclitol derivative featuring a fused dimethylaminooxazoline ring. It is structurally related to the natural product allosamidin and has been reported as an experimental compound with no approved medical indications. Allosamizoline has been identified in Streptomyces species and studied primarily for its biochemical properties rather than clinical use. Its mechanism of action is not fully characterized in humans; however it is known as a structural component or analog in research on chitinase inhibitors due to its similarity to allosamidin derivatives[1][2][7]. There are no approved therapeutic uses or clinical trials involving this compound.

Other names
(3aR,4R,5R,6R,6aS)-2-(dimethylamino)-6-(hydroxymethyl)-3aH,4H,5H,6H,6aH-cyclopenta[d][1,3]oxazole-4,5-diol(3aR,4R,5R,6R,6aS)-2-(dimethylamino)-6-(hydroxymethyl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]oxazole-4,5-diol

Beyond the preview

Go deeper on allosamizoline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on allosamizoline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call